Survey: 4-in-5 Americans report condom use is important
EWING, N.J. — According to new research released Wednesday by Church & Dwight, 80% of American adults say condom use is important to them, however, only 35% report always using a condom.
The study, which examined condom attitudes and behaviors among American adults, found that among those with a repeat partner who reported not using a condom each and every time, close to 50% stopped using them regularly by month one and 62% stopped by month two. The research also found that while 75% of those surveyed agreed it's a shared responsibility for men and women to bring up condom use, the man is largely relied on to purchase and provide them.
In addition to the early drop-off rate, the research showed that nearly 40% of people who didn't use a condom during their last sexual experience reportedly did so without discussing it first.
When asked why they stopped using condoms, study participants cited commitment, trust and exclusivity as the top reasons for discontinuing the use of condoms. However, according to the research, 60% indicated they had not been tested for STDs, two-thirds indicated their partner had not been tested and more than 1-in-3 are not using another form of hormonal birth control.
Findings show that 60% of adults experience regret and stress after having sex without a condom due to worrying about STDs and/or pregnancy.
"Trust and respect for a partner are two important aspects in any relationship," stated Matthew Hussey, relationship expert and Trojan spokesperson. "Even though your relationship status may change, your sexual health status doesn't, so it's essential to have an honest conversation about using condoms, which ultimately shows your partner that you respect them and leads to a more enjoyable and healthy sex life."
Realizing the importance of encouraging more conversations about condoms, especially in light of the high drop-off rate of condom use within two months of a relationship, Trojan has partnered with MTV on a three-part content series that encourages the condom conversation between couples and reinforces the importance of continued usage. Created in collaboration with MTV's long-standing "It's Your (Sex) Life" responsible sexual health campaign, the "Co Zone Convos" series, which will begin airing on MTV on Wednesday, Sept. 10, portrays realistic condom conversations between couples among friends, helping to ease the moment of decision and remind viewers of the positive benefits of consistent condom use in a relationship.
"Condoms should play an important role in relationships, as they are the only contraceptive method that protects against both pregnancy and sexually transmitted infections and are 98% effective at preventing unintended pregnancy when used consistently and correctly," said Bruce Weiss, VP marketing for Trojan Condoms. "But condoms are exiting relationships early, with little to no discussion about the decision. Trojan wants to make this discussion easier and empower women and men to speak up, have the conversation and take charge of their sexual health."
Dollar General takes $9.1 billion offer directly to Family Dollar shareholders
GOODLETTSVILLE, Tenn. — Dollar General on Wednesday announced that it has commenced a tender offer to acquire all outstanding shares of Family Dollar stores for $80.00 per share in cash. This represents a premium to the closing price of $78.70 per Family Dollar share as of Tuesday.
The offer is scheduled to expire at 5 p.m., EST, on Oct. 8, unless the offer is extended.
Dollar General also will promptly file for clearance under the Hart-Scott-Rodino Act, which will allow the company to begin the antitrust approval process with the Federal Trade Commission.
"Our offer provides Family Dollar shareholders with significantly greater value than the existing agreement with Dollar Tree, as well as immediate and certain liquidity for their shares," stated Rick Dreiling, chairman and CEO of Dollar General. "By taking this step, we are providing all Family Dollar shareholders a voice in this process, and we urge them to tender into our offer."
"Additionally, we now can begin the antitrust review process and will have an opportunity to present our position directly to the FTC. As we previously have stated, we are confident in the results of our antitrust analysis, and we look forward to a constructive dialogue with the FTC," Dreiling said.
According to Dollar General, Dollar General's all-cash offer of $80.00 per share provides Family Dollar shareholders with a substantially superior valuation to the $74.50 per share cash / stock offer announced by Dollar Tree on July 28, 2014. Dollar General's offer provides Family Dollar's shareholders with approximately $640 million of additional aggregate value over Dollar Tree's offer and represents a premium of 31.9% over the closing price of $60.66 for Family Dollar stock on the day prior to the Dollar Tree announcement.
The offer is not conditioned upon any financing arrangements. Dollar General has received written financing commitments that are in full force and effect from Goldman, Sachs & Co. and Citigroup Global Markets for all of the financing necessary to consummate the proposed all-cash transaction.
Goldman, Sachs & Co. is acting as financial advisor to Dollar General. KKR Capital Markets and MCS Capital Markets are advising the company on the financing. Simpson Thacher & Bartlett is acting as its legal counsel.
iWalkFree introduces hands-free crutch
LONG BEACH, Calif. — iWalkFree recently launched the new iWalk2.0, a hands free crutch which some refer to as the “Pirate Leg Crutch.” The iWalk2.0 is used for all lower leg injuries and recruits the uninjured upper leg instead of the hands and arms as with conventional crutches. This allows the user to walk on both legs with only minor gait adaptation.
“Over four million people buy crutches in the U.S. alone,” stated Brad Hunter, director of business development for iWalkFree. “Walking and standing is intuitive, efficient and pain free. Most users are iWalking in less than a minute.”
The iWalk2.0 made its debut at Medtrade in Orlando, Florida in October 2013 and was awarded the Innovation Award as the best product of the show. They also won awards for Best Product and Best New Product. iWalk2.0 has also earned Best New Product honors at ECRM earlier this year.
“We’re proud to have gained the recognition and acceptance of the industry, but more important, this helps validate that the technology works," Hunter said. "It’s difficult to bring a new concept to market, and achieving the buy-in of the medical device community is our first step in bringing a main stream awareness that the days of suffering on crutches are over.”
The iWalk2.0 has a retail price of $149.00 and can be worn by anyone with average strength and balance.
Loading Post Please Wait...